Lehman & Derafelo Financial Resources LLC Clovis Oncology, Inc. Put Options Transaction History

Lehman & Derafelo Financial Resources LLC

  • $337 Million
  • Q4 2022

Put Options

2 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2020

Jan 20, 2021
SELL
$4.13 - $6.41 $82,600 - $128,200
-20,000 Closed
0 $0
Q3 2020

Nov 06, 2020
BUY
$4.82 - $7.72 $96,400 - $154,400
20,000 New
20,000 $117,000

Others Institutions Holding CLVS

# of Institutions
1
Shares Held
166
Call Options Held
0
Put Options Held
0
View Full List

About Clovis Oncology, Inc.

CLVS Quotes by TradingView
  • Ticker CLVS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 144,480,000
  • Market Cap $13M
  • Description
  • Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...
More about CLVS
Track This Portfolio

Track Lehman & Derafelo Financial Resources LLC Portfolio

Follow Lehman & Derafelo Financial Resources LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lehman & Derafelo Financial Resources LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lehman & Derafelo Financial Resources LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email